India's Smart IPO
Discovery Platform

India’s pharmaceutical manufacturing industry is witnessing growing opportunities in injectables, driven by rising healthcare demand, complex therapies, global outsourcing and increasing focus on high-quality drug manufacturing. Explore how the injectable segment could shape the next phase of growth in pharma manufacturing.

Learn how to read and evaluate a mutual fund before investing. This simple guide explains key factors such as fund performance, expense ratio, fund manager, portfolio holdings, risk level and other important metrics to help investors understand a mutual fund better.

Morgan Stanley has highlighted six Indian energy stocks across refining, upstream exploration, power generation and electricity infrastructure. The report reflects key sector themes including resilient energy demand, refining margins, domestic exploration and rising power consumption in India.

PC Jeweller has become debt-free after clearing dues to all 14 consortium banks, marking a major balance-sheet milestone. The development comes as the stock has rallied sharply, while strong Q1 FY27 profit and revenue growth put the company’s financial recovery and future performance in focus.

Moneyview IPO opens on September 24, 2026, with a ₹1,091.68 crore issue at a price band of ₹32–₹34 per share. With GMP indicating a potential 32% listing premium, the IPO has attracted investor attention. Here’s a look at its key details, financial performance, IPO proceeds and important factors to watch

India’s IPO market could raise up to ₹2 lakh crore as fresh capital gains prominence. With strong domestic investor participation, rising market depth and SEBI-led reforms, IPOs are increasingly becoming an important source of growth capital for Indian companies.